This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Salmon, J E Articles by Holers, V M Search for Related Content PubMed PubMed Citation Articles by Salmon, J E Articles by Holers, V M Social Bookmarking                         What's this?

Activation of complement mediates antiphospholipid antibody-induced pregnancy loss

Department of Medicine, Hospital for Special Surgery-Weill Medical College, Cornell University, New York, USA, salmonj{at}hss.edu

G Girardi

Department of Medicine, Hospital for Special Surgery-Weill Medical College, Cornell University, New York, USA

V M Holers

Departments of Medicine and Immunology, University of Colorado Health Sciences Center, Denver, Colorado, USA

Although it is clear that the specific antigenic reactivityof antiphospholipid(aPL) antibodiesis critical to their effect, the pathogenicmechanisms that resultin injury in vivo are incompletelyunderstood.We hyphothesized that aPL antibodies targeted to the placenta activate complement locally, generating split products that mediate placental injury and lead to foetal loss and growth retardation. To test this hypothesis, we used a murine model of APS in which pregnant mice are injected with human IgG containing aPL antibodies. Mice treated with inhibitors of complement activation and mice deficient in complement components were protected from aPL antibody-inducedfoetal damage. Although the cause of tissue injury in this disease is probably multifactoral, we have shown that complement activation is an absolute requirement for foetal loss and growth restriction and, therefore, that this pathway acts upstream of other important effector mechanisms. Identification of complement activation as a mechanism that is necessary for aPL-induced tissue damage and definition of the complement components necessary to trigger such injury is likely to lead to a better understandingof the pathogenesis of vascular and tissue injury in SLE and to new and improved treatments.

Key Words: complement • complement inhibitory protein • C3 • neutrophils

Lupus, Vol. 12, No. 7, 535-538 (2003)
DOI: 10.1191/0961203303lu397oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. F. Smith Jr and M. L. Druzin Perinatal Implications of the Antiphospholipid Syndrome NeoReviews, May 1, 2007; 8(5): e206 - e213. [Abstract] [Full Text] [PDF]

				N Schwartz, Y Shoenfeld, O Barzilai, R Cervera, J Font, M Blank, S Yacobi, N Patlas, A Cohen, D Mevorach, et al. Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS Lupus, February 1, 2007; 16(2): 110 - 120. [Abstract] [PDF]

				S. D. Fleming, R. P. Egan, C. Chai, G. Girardi, V. M. Holers, J. Salmon, M. Monestier, and G. C. Tsokos Anti-Phospholipid Antibodies Restore Mesenteric Ischemia/Reperfusion-Induced Injury in Complement Receptor 2/Complement Receptor 1-Deficient Mice J. Immunol., December 1, 2004; 173(11): 7055 - 7061. [Abstract] [Full Text] [PDF]

				S. D. Fleming, M. Monestier, and G. C. Tsokos Accelerated Ischemia/Reperfusion-Induced Injury in Autoimmunity-Prone Mice J. Immunol., September 15, 2004; 173(6): 4230 - 4235. [Abstract] [Full Text] [PDF]